Zelira Therapeutics Ltd Capital Reinvestment Ratio
Zelira Therapeutics Ltd capital reinvestment ratio. Zelira Therapeutics Ltd (ZLD) has a Capital Reinvestment Ratio of 0.23x as of December 2015, meaning it reinvests 0% of its operating cash flow (AU$159.61K) in capital expenditures (AU$36.80K). Check Zelira Therapeutics Ltd (ZLD) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zelira Therapeutics Ltd (2011–2011)
Capital reinvestment ratio of Zelira Therapeutics Ltd from 2011 to 2011. This chart tracks Zelira Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore how fast is Zelira Therapeutics Ltd growing its equity to track the company's year-over-year net asset growth rate.
Zelira Therapeutics Ltd Capital Reinvestment Ratio by Year (2011–2011)
Zelira Therapeutics Ltd capital reinvestment ratio by year from 2011 to 2011. For the full cash flow conversion analysis, see ZLD cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2011 | 0.14x | AU$101.92K | AU$13.95K | — |